FTC and Plaintiff States v. Amgen, No. 23-CV-3053 (N.D. Ill. 06/22/23)
Plaintiff states joined the Federal Trade Commission’s suit against Amgen’s planned $28 billion purchase of Horizon Therapeutics. The plaintiffs sought a temporary restraining order and preliminary injunction blocking Amgen Inc. and its subsidiaries from completing the proposed acquisition. Horizon Therapeutics PLC makes the only U.S. FDA-approved treatment for thyroid eye disease, Tepezza, and the only FDA-approved…
California ex rel. Bonta v. KYB Copr.
As part of a large class action, plaintiff state filed suit against manufacturers of automotive shock absorbers, alleging that the defendants, from the mid-1990s through at least 2012, conspired to rig bids for, and to fix stabilize and maintain the price of shock absorbers installed in autos purchased by the plaintiff state. Defendant pled guilty…
Utah et al. v. Google LLC, No. 3:21-cv-05227 (N.D. Cal. July 7, 2021)
Thirty-seven states filed a lawsuit against Google for monopolizing the smartphone application market in violation of state and federal antitrust laws. According to the complaint, Google operates a web of exclusionary agreements with phone manufacturers and carriers to exert control over app distribution on Android phones through its Google Play Store. By leveraging those anticompetitive…
Alabama et al. v. Endo International, No. 3:19-cv-04157 (N.D. Cal. July 19, 2019)
Eighteen states reached a settlement with Endo Pharmaceuticals Inc. under which Endo paid $2.3 million to settle allegations it entered into a reverse-payment agreement to obstruct generic competition to Lidoderm, a pain relief patch frequently used to treat shingles. According to the complaint, Endo had an agreement with Watson Laboratories Inc. ensuring Endo would not face…
FTC et al. v. Vyera Pharmaceuticals, No. 1:20-cv-00706 (S.D.N.Y. Apr. 19, 2020)
The FTC, New York and six other states filed suit against Vyera Pharmaceuticals, its parent company, Phoenixus and its former officers, Kevin Mulleady and Martin Shkreli, alleging anticompetivie conduct in connection with Daraprim, the only FDA approved drug for the treatment of the life-threatening parasitic disease toxoplasmosis. The suit alleges that Vyera purchases the unpatented…
Maryland v. Bong Soo Ha, Civ. No. 148715 (Cir. Ct. For Montgomery Co. 1996)
Defendants met at various Korean restaurants and set the prices they would charge retailers for Korean language videos.
Maryland v. ARC Asbestos Removal Co., Coastal Insulation, Inc., Edward J. Hayes & Nicholas D. Thrappas, Civ. No. 90187046/CL 116120 (Cir. Ct. for Baltimore City 1990).
Civil Consent Decree following criminal bid-rigging guilty plea.
Maryland v. Jensema, et al., No. 3-C-96-1205 (Cir. Ct. for Baltimore Co. 1996).
Impartial Hearing Officers, through their trade association and individually, agreed to set fees for presiding over special education appeal hearings.
Maryland v. Kimberly-Clark Corp., et al. No. 24-C-99-004904 (Cir. Ct. for the City of Baltimore 1999).
Related to Florida’s Sanitary Paper case – price-fixing among manufacturers of sanitary paper products (tissue, napkins, etc. used in commercial or institutional context).
Maryland and Maryland Stadium Authority v. National Football League, et al., Civ. No. 6 96-155 (D. Md. 1996).
Case sought to enjoin NFL from preventing Art Modell from moving the Cleveland Browns from Cleveland to Baltimore.
